Evaluating the role of HR 3D-CBCT and squid 12® embolic agent in meningioma management: Insights from MRI modifications at follow-Up - 18/06/25
, Antonio Macera c, Claudia Rollo c, Amedeo Cervo c, Branko Popadic d, Alessandro La Camera eAbstract |
We report three cases of meningiomas treated with Squid 12® with their peculiar technical aspects. High-resolution 3D cone-beam CT angiography (HR 3D-CBCT) was used to evaluate the tumor’s vascular anatomy and guide embolization, revealing pial arterial supplies not readily visible on standard angiography. Squid 12® achieved deep tumor penetration, abolishing contrast enhancement on immediate post-procedural MRI. Follow-up MRIs showed progressive tumor shrinkage, with peripheral ring enhancement and decreased edema. Tumor volume was reduced by approximately 50% at the 4-6 months follow-up, leading to a delay in SRS for further stabilization and clinical improvement in the symptomatic patients.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Highlights |
• | HR 3D-CBCT improves the preoperative evaluation of the arterial feeders of the meningiomas. |
• | Squid 12 has a higher ability to fill the tumor vessels compared to other embolization materials. |
• | After massive embolization with Squid 12, meningiomas present peculiar modifications at the MRI that had never been described before. |
Keywords : Meningioma embolization, High-resolution cone-beam CT, Endovascular treatment, EVOH
Plan
| Disclaimers: All authors confirm that what expressed in this manuscript was not influenced by any external institutional or economical interest. |
|
| This study did not receive any external economic support. The study has never been presented in any congress or meeting. |
Vol 52 - N° 4
Article 101346- juin 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
